Outcomes of Grade Group 2 and 3 Prostate Cancer on Initial Versus Confirmatory Biopsy: Implications for Active Surveillance.
Saved in:
| Title: | Outcomes of Grade Group 2 and 3 Prostate Cancer on Initial Versus Confirmatory Biopsy: Implications for Active Surveillance. |
|---|---|
| Authors: | Perera M; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Jibara G; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Tin AL; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Haywood S; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Sjoberg DD; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Benfante NE; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Carlsson SV; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Eastham JA; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Laudone V; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Touijer KA; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Fine S; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Scardino PT; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Vickers AJ; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Ehdaie B; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: ehdaieb@mskcc.org. |
| Source: | European urology focus [Eur Urol Focus] 2023 Jul; Vol. 9 (4), pp. 662-668. Date of Electronic Publication: 2022 Dec 23. |
| Publication Type: | Review; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101665661 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2405-4569 (Electronic) Linking ISSN: 24054569 NLM ISO Abbreviation: Eur Urol Focus Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36566100 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Outcomes of Grade Group 2 and 3 Prostate Cancer on Initial Versus Confirmatory Biopsy: Implications for Active Surveillance. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Perera+M%22">Perera M</searchLink>; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Jibara+G%22">Jibara G</searchLink>; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Tin+AL%22">Tin AL</searchLink>; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Haywood+S%22">Haywood S</searchLink>; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Sjoberg+DD%22">Sjoberg DD</searchLink>; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Benfante+NE%22">Benfante NE</searchLink>; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Carlsson+SV%22">Carlsson SV</searchLink>; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Eastham+JA%22">Eastham JA</searchLink>; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Laudone+V%22">Laudone V</searchLink>; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Touijer+KA%22">Touijer KA</searchLink>; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Fine+S%22">Fine S</searchLink>; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Scardino+PT%22">Scardino PT</searchLink>; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Vickers+AJ%22">Vickers AJ</searchLink>; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Ehdaie+B%22">Ehdaie B</searchLink>; Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: ehdaieb@mskcc.org. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101665661%22">European urology focus</searchLink> [Eur Urol Focus] 2023 Jul; Vol. 9 (4), pp. 662-668. <i>Date of Electronic Publication: </i>2022 Dec 23. – Name: TypePub Label: Publication Type Group: TypPub Data: Review; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+B%2EV%22">Elsevier B.V </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>101665661 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2405-4569 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224054569%22">24054569 </searchLink><i>NLM ISO Abbreviation: </i>Eur Urol Focus <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36566100 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.euf.2022.12.008 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 662 Titles: – TitleFull: Outcomes of Grade Group 2 and 3 Prostate Cancer on Initial Versus Confirmatory Biopsy: Implications for Active Surveillance. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Perera M – PersonEntity: Name: NameFull: Jibara G – PersonEntity: Name: NameFull: Tin AL – PersonEntity: Name: NameFull: Haywood S – PersonEntity: Name: NameFull: Sjoberg DD – PersonEntity: Name: NameFull: Benfante NE – PersonEntity: Name: NameFull: Carlsson SV – PersonEntity: Name: NameFull: Eastham JA – PersonEntity: Name: NameFull: Laudone V – PersonEntity: Name: NameFull: Touijer KA – PersonEntity: Name: NameFull: Fine S – PersonEntity: Name: NameFull: Scardino PT – PersonEntity: Name: NameFull: Vickers AJ – PersonEntity: Name: NameFull: Ehdaie B IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 07 Text: 2023 Jul Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 2405-4569 Numbering: – Type: volume Value: 9 – Type: issue Value: 4 Titles: – TitleFull: European urology focus Type: main |
| ResultId | 1 |